Biofrontera Stock Market Value
| BFRI Stock | USD 0.82 0.02 2.50% |
| Symbol | Biofrontera |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biofrontera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biofrontera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biofrontera.
| 12/11/2025 |
| 01/10/2026 |
If you would invest 0.00 in Biofrontera on December 11, 2025 and sell it all today you would earn a total of 0.00 from holding Biofrontera or generate 0.0% return on investment in Biofrontera over 30 days. Biofrontera is related to or competes with Gelteq Limited, ProPhase Labs, Aytu BioScience, Evogene, Dogwood Therapeutics, Sensei Biotherapeutics, and Trinity Biotech. Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treat... More
Biofrontera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biofrontera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biofrontera upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 32.71 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 6.76 |
Biofrontera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biofrontera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biofrontera's standard deviation. In reality, there are many statistical measures that can use Biofrontera historical prices to predict the future Biofrontera's volatility.| Risk Adjusted Performance | 0.006 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.02) |
Biofrontera Backtested Returns
Biofrontera secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Biofrontera exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biofrontera's Standard Deviation of 6.08, mean deviation of 3.74, and Risk Adjusted Performance of 0.006 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.9, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biofrontera will likely underperform. At this point, Biofrontera has a negative expected return of -0.0424%. Please make sure to confirm Biofrontera's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Biofrontera performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.15 |
Insignificant reverse predictability
Biofrontera has insignificant reverse predictability. Overlapping area represents the amount of predictability between Biofrontera time series from 11th of December 2025 to 26th of December 2025 and 26th of December 2025 to 10th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biofrontera price movement. The serial correlation of -0.15 indicates that less than 15.0% of current Biofrontera price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Biofrontera lagged returns against current returns
Autocorrelation, which is Biofrontera stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biofrontera's stock expected returns. We can calculate the autocorrelation of Biofrontera returns to help us make a trade decision. For example, suppose you find that Biofrontera has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biofrontera regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biofrontera stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biofrontera stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biofrontera stock over time.
Current vs Lagged Prices |
| Timeline |
Biofrontera Lagged Returns
When evaluating Biofrontera's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biofrontera stock have on its future price. Biofrontera autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biofrontera autocorrelation shows the relationship between Biofrontera stock current value and its past values and can show if there is a momentum factor associated with investing in Biofrontera.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Biofrontera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biofrontera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biofrontera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biofrontera Stock:Check out Biofrontera Correlation, Biofrontera Volatility and Biofrontera Alpha and Beta module to complement your research on Biofrontera. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Biofrontera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.